aurintricarboxylic acid has been researched along with salicylates in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buckheit, RW; Casimiro-Garcia, A; Cushman, M; De Clercq, E; Fanwick, PE; Loftus, TL; Pannecouque, C; Turpin, JA; Witvrouw, M | 1 |
LINDENBAUM, A; SCHUBERT, J | 1 |
SCHUBERT, J; WHITE, MR | 1 |
Guo, JP; Lee, M; McGeer, EG; McGeer, PL; Schwab, C | 1 |
Alptürk, O; Sheen, CW; Sluis-Cremer, N | 1 |
5 other study(ies) available for aurintricarboxylic acid and salicylates
Article | Year |
---|---|
Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments.
Topics: Anti-HIV Agents; Aurintricarboxylic Acid; CD4 Antigens; Cell Survival; Drug Design; HIV Envelope Protein gp120; HIV-1; HIV-2; Humans; Inhibitory Concentration 50; Salicylates; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
Studies on the mechanism of protection by aurintricarboxylic acid in beryllium poisoning. II. Equilibria involving alkaline phosphatase.
Topics: Alkaline Phosphatase; Anthelmintics; Aurintricarboxylic Acid; Berylliosis; Beryllium; Coloring Agents; Phosphoric Monoester Hydrolases; Salicylates | 1954 |
Studies on the mechanism of protection by aurintricarboxylic acid in beryllium poisoning. IV. Comparative effects of related compounds on survival of Be-poisoned animals and on distribution of Be.
Topics: Animals; Aurintricarboxylic Acid; Beryllium; Coloring Agents; Gentisates; Poisoning; Salicylates | 1954 |
Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex.
Topics: Alzheimer Disease; Animals; Aurintricarboxylic Acid; Bystander Effect; Complement System Proteins; Hemolysis; Humans; Memory; Mice; Mice, Transgenic; Rats; Salicylates | 2012 |
Novel high-throughput screen identifies an HIV-1 reverse transcriptase inhibitor with a unique mechanism of action.
Topics: Fluorescence Resonance Energy Transfer; High-Throughput Screening Assays; HIV Reverse Transcriptase; Kinetics; Reverse Transcriptase Inhibitors; Salicylates; Virus Replication | 2014 |